# GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections

Study · id `cardio:ct-nct06827990` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06827990](<https://clinicaltrials.gov/study/NCT06827990>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06827990

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 112 participants.

## Technical summary

Registry record NCT06827990. Non-randomized; no masking; primary purpose treatment. Start 2025-09-22 (actual); primary completion 2030-09-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 112 participants (planned count; ClinicalTrials.gov record NCT06827990, source copy `cardio:ctgov-nct06827990-2026-10-23`, retrieved 2026-11-18)
- Started: 2025-09-22 (actual) (ClinicalTrials.gov record NCT06827990, source copy `cardio:ctgov-nct06827990-2026-10-23`, retrieved 2026-11-18)
- Primary completion: 2030-09-01 (anticipated) (ClinicalTrials.gov record NCT06827990, source copy `cardio:ctgov-nct06827990-2026-10-23`, retrieved 2026-11-18)
- Completion: 2031-09-01 (anticipated) (ClinicalTrials.gov record NCT06827990, source copy `cardio:ctgov-nct06827990-2026-10-23`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT06827990, source copy `cardio:ctgov-nct06827990-2026-10-23`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06827990-2026-10-23`, retrieved 2026-11-18)

## The registry's words

- Brief title: GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
- Acronym: ARISE III
- Condition: Aortic Dissection
- Intervention (Device): GORE® Ascending Stent Graft (ASG device)
- Lead sponsor: W.L.Gore & Associates
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic dissection (`cardio:aortic-dissection`)
- Registry lists this organization as the lead sponsor: W.L.Gore & Associates (`cardio:org-w-l-gore-associates`)

## Provenance

Content hash: 265f6cf3fd97b65c34470cc84aac7f5e325a4a0153849a83b3aba16065bfee9b
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
